HUPOST Editor: Aleksandra Nita-Lazar | Staff Editor: Olivia Galun | March 2024
|
|
HUPO 2024 will provide a unique opportunity to present and discuss advancements in the interdisciplinary field of proteome research. Make plans now to attend this outstanding congress!
Share your latest findings with the proteomics community by submitting your abstract and becoming part of the scientific program. Deadline for submission: May 31, 2024 (There will be no deadline extension!)
Find the latest program updates here
There are several funding options available - Apply Here
Request for Proposals for Pre-Congress Sessions
The Congress Organizing Committee is asking for proposals for session topics to be included in the Pre-Congress program on Sunday, October 20 at HUPO 2024. In total, six sessions (each 90 minutes) will be available and organized in two parallel streams. One stream will be focused on “How to translate proteomic data into biological/clinical insights” and thus we particularly encourage proposals addressing this thematic area.
Please submit a short description of the potential pre-congress session including potential speakers to [email protected] The deadline for submitting proposals is March 29, 2024.
The HUPO Early Career Researcher (ECR) Committee was founded in 2015 and has since actively and tirelessly promoted the transmission of HUPO values to the next generation of proteomic leaders, who are actively involved in many of the varied HUPO initiatives and activities. Mentoring represents the strongest link between generations of scientists, which is why the HUPO ECR, teaming up this year with the Young Proteomics Investigators Club (YPIC) of the European Proteomics Association (EuPA), is pleased to present a variety of awards and activities in conjunction with HUPO’s Annual World Congress.
|
|
It's that time of year again - HUPO Awards season! Nomination forms are coming soon and will be available in this newsletter as well as on the HUPO website. See previous award winners here and start thinking now of candidates you may wish to nominate for the following 2024 HUPO awards:
- Discovery in Proteomic Sciences Award
- Rising Star Award
- Clinical and Translational Proteomics Award
- Science and Technology Award
- Distinguished Achievement in Proteomic Sciences Award
|
|
In recognition and appreciation of the significant support, participation and guidance provided by HUPO's Industrial Advisory Board (IAB), one IAB member will be highlighted each month. We encourage you to connect with these companies directly for further information about their involvement in HUPO, and their products and services. |
|
Sengenics is a functional proteomics company that leverages its patented KREX® technology to develop high-density arrays displaying full-length, correctly-folded proteins. Specializing in the discovery and validation of autoantibody biomarker signatures, we offer both custom and preset panels encompassing over 1800 proteins.
Our protein arrays offer distinct advantages over alternative tools for autoantibody screening, including:
-
Precision: With 90% of humoral antibodies binding conformational epitopes, KREX technology ensures correctly folded proteins for accurate results (see Figure)
-
Reproducibility: Proteins maintain the same orientation across arrays, guaranteeing high reliability and consistency
-
Advanced Analysis: Incorporating modern machine learning and advanced algorithms, our expert bioinformatics team delivers meaningful data
Whether used alone or in combination with other omics, data obtained with KREX technology provides direct understanding of the humoral immune response to aid in identifying disease-associated proteins. These data help translate complex disease profiles into actionable clinical insights for early disease detection, precise patient stratification, accurate prediction of therapeutic responses, and the development of companion diagnostics.
Headquartered in Greater Boston, Massachusetts, USA, and supported by a global network of offices, distributors, and service providers, Sengenics remains committed to advancing personalized medicine worldwide.
|
|
KREX protein-folding technology. Every protein is tagged with a biotin carboxy carrier protein (BCCP) that binds to biotin only when correctly folded. The proteins are then anchored to the array surface through a stable biotin-streptavidin bond. Misfolded proteins result in a BCCP that cannot bind to biotin, and are consequently washed away and removed from further analysis.
|
|
Speaker: Rosa Isela Gallagher, PhD
Date: Wednesday, March 20, 2024
Time: 2pm PST / 5pm EST / 10pm CET
Webinar Description: RPPA is a high-throughput protein array technology that simultaneously measures hundreds or thousands of samples on glass slides with high precision and reliability, using specific antibodies. RPPA and mass spectrometry-based protein profiling are complementary technologies for protein profiling. In attending this webinar, attendees will learn about RPPA's high-throughput capabilities and laser-captured microdissection technology. They will understand how these technologies precisely measure protein expression, modifications, and phosphorylation in tumor cells.
|
|
Last Chance to Vote for Your Favourite Mentoring Session Topic at HUPO 2024
The HUPO Early Career Researcher (ECR) Committee organizes mentoring sessions during the HUPO World Congress to foster a space for professional development and mentorship. Three mentoring sessions will take place at HUPO 2024 in Dresden, Germany. To select the topics to be covered, we would love to hear from the early career researcher proteomics community! Be part of the decision-making process and share your insights in our anonymous survey tailored for those shaping the future of research.
The survey closes March 11, 2024 at 11:59pm HST
|
|
Apply for the HUPO 2024 Early Career Researcher Manuscript Competition
Seize the opportunity to showcase your recent achievements in the dynamic field of proteomics! We invite early career researchers to apply for the 10th edition of the HUPO Early Career Researcher (ECR) Manuscript Competition, taking place at the HUPO 2024 World Congress in Dresden, Germany, October 20-24. This competition offers a unique platform for postdoctoral fellows, young clinicians, and junior faculty members to gain visibility within the proteomics community, emphasizing their significant contributions to the field.
|
|
The 3-Minute Thesis Competition Returns at HUPO 2024
Building on the success of previous 3-Minute Thesis Competitions, the HUPO Early Career Researcher (ECR) Committee and the Human Proteome Project (HPP) team up once again to provide this engaging competition. Present your proteomics Ph.D. thesis topic in 3 minutes using a single static slide and in a format that can be understood by a general audience.
|
|
Submit Your Abstract and Participate in the Poster Competition at HUPO 2024
The HUPO Early Career Researcher (ECR) Committee is excited to present this year’s Poster Competition sponsored by Molecular Omics. All graduate students (Master’s and PhD), as well as postdocs, are invited to participate in the HUPO 2024 poster competition taking place October 20-24, 2024 in Dresden, Germany.
|
|
In a new monthly feature within HUPOST, we will be highlighting extraordinary HUPO volunteers who lead and support many of HUPO's various Committees and Initiatives. If you would like to volunteer with HUPO, please connect with the HUPO Office.
HUPO Marketing and Outreach Committee (MOC)
The MOC has been at work developing new ways to promote the HUPO mission, the visibility of proteomics within the scientific community and its popularization among the public, as well as gathering funding support. The MOC has been very successful in networking with other HUPO Committees and Initiatives and using a range of tools and activities. The MOC members are from different fields and backgrounds and at various career stages representing the diversity of HUPO.
|
|
James Waddington (Chair) is an LC-MS Application Specialist at Agilent Technologies based in the UK. In his role James supports customers across Europe on a range of omics workflows relating to Life Science research. Having completed his PhD in Clinical and Molecular Pharmacology at the University of Liverpool, focused on the field of immunopeptidomics, James moved to Ireland to work under the supervision of Professor Stephen Pennington at University College Dublin (UCD). Soon after, James managed strategic research agreements and led product development within Atturos Ltd., a clinical diagnostics company developing the next generation of molecular diagnostic tests. Using Agilent LC-MS to develop Atturos peptide biomarker panels directed him to his current position within Agilent, where he relocated back to the UK in early 2023. James has been an active member of the MOC since December 2019, where he has taken the position of co-chair, in addition to sitting on the board of directors for the British Society for Proteome Research (BSPR).
|
|
The HUPO Education and Training Committee (ETC) and the Early Career Researcher Committee (ECR), as well as other HUPO Initiatives (e.g. B/D HPP, Single Cell) have been hard at work organizing and providing very helpful and interesting webinars for the proteomics community. Recordings of these webinars can be found on the HUPO website here.
If you have any ideas or suggestions for webinar topics, please send an email to the HUPO Office and we’ll be sure to pass them along!
|
|
(Portland, USA)
(Kyoto, Japan)
(Madrid, Spain)
(Rouen, France)
(South Tyrol, Italy)
(Dresden, Germany)
(Saint-Malo, France)
|
|
The job board on the HUPO website is a valuable resource for both employers and individuals seeking ideas and opportunities.
If you have a job posting and would like to advertise it, send your information to [email protected]. For more information and job listing details - visit the website here.
|
|
Disclaimer: HUPOST provides general information for subscribers. Submissions are welcomed from HUPO members. Articles are to be submitted to HUPO office by 20th of each month (date subject to change without notice) for review by the Editor for suitability. HUPO assumes no liability for errors or omissions in the contents. |
|
|
|
|
|
|
